Using time-in-range to assess risk for complications, Omnipod Horizon Closed Loop, Bihormonal closed loop (insulin + Pramlintide), SGLT-2 oral drug for type 1, and more!

U500 insulin delivery through Omnipod pump, comparing insulin secretion between Mediterranean and ketogenic meals, a head-to-head with Afrezza and NovoLog, Qtern...

CGM accuracy, meal timing, n ew partnerships in diabetes tech, vitamin D for prediabetes, and more!

The most promising therapies in the pipeline, accuracy data on the FreeStyle Libre 2, and more

Data on type 2 diabetes therapies and prevention, Medtronic MiniMed 780G trial starts, Beta Bionics Gen 3 iLet time-in-range results, and more!

SGLT-1/2 therapy for type 1 diabetes, hybrid closed loop systems in teens and children, and the importance of glucose control as an outcome in addition to A1C!

First drug trial to show delay in type 1 diagnoses, heart and kidney benefits from Trulicity in type 2, huge focus on time-in-range, positive results for both Tandem’s...

CGM data in people without diabetes, time-in-range and A1C benefits in large hybrid closed loop study, plus trial results studying Jardiance in type 1 as well as Lilly’s...

Big focus on heart health outcome trials with PIONEER 6 and CAROLINA in the spotlight; plus promising CGM data in adolescents with type 1 diabetes

The benefits of measuring time in range, plus new care guidelines for adults with type 2 diabetes

How we talk about diabetes matters; using empowering, non-stigmatizing words is important when speaking with and about people with diabetes

Insightful diabetes leaders discuss high-potential areas ranging from SGLT-2s in type 1 diabetes, personalized treatment plans, and the do-it-yourself Loop app

News from Onduo's virtual diabetes clinic, Klue, SugarMate, and Diabits apps, Tidepool Loop, and more!

Learn more about JDRF’s efforts in finding a cure for type 1 diabetes and read highlights from experts’ discussions on SGLT inhibitors in type 1 and Beyond A1C

Over 160 children and teens living with type 1 diabetes were selected to travel to Washington D.C. for three days, meeting with politicians and lawmakers to advocate for...

A preview of the most exciting conference updates on diabetes drugs, devices, and more; stay tuned!

The diaTribe team was on the ground at the 2019 ADA 79th Scientific Sessions to share several of the greatest highlights from the conference!

The diaTribe Foundation’s sixth annual “Solvable Problems in Diabetes” in Barcelona brought together more than 140 leaders to discuss challenges and opportunities in...

What I've Learned From 70,000 Hours Wearing CGM - A Video Presentation at Thriveabetes 2019

The first ever “Closed Loop Showcase”; Ascensia’s diabetes coaching and bundled program; excitement for UnderMyFork app